Hepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C

dc.contributor.authorGunal, E.
dc.contributor.authorCelen, M. K.
dc.date.accessioned2024-04-24T16:14:54Z
dc.date.available2024-04-24T16:14:54Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.ijid.2014.03.1065
dc.identifier.endpage311en_US
dc.identifier.issn1201-9712
dc.identifier.issn1878-3511
dc.identifier.startpage311en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijid.2014.03.1065
dc.identifier.urihttps://hdl.handle.net/11468/15495
dc.identifier.volume21en_US
dc.identifier.wosWOS:000209704000648
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofInternational Journal of Infectious Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword]en_US
dc.titleHepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis Cen_US
dc.titleHepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C
dc.typeConference Objecten_US

Dosyalar